October 12, 2022
Article
Pediatric populations are disproportionately affected by influenza. The first cell-based quadrivalent flu vaccine offers potential for greater vaccine effectiveness.
October 04, 2022
The CDC is urging all eligible persons to receive a flu shot, but a new survey shows fewer adults are planning to get the vaccine this season.
August 29, 2022
A new study found that patients hospitalized with COVID-19 are at significantly higher risk for venous thromboembolism in the ensuing 3 months than are patients hospitalized with influenza.
August 12, 2022
The FDA has approved Baloxavir Marboxil (Xofluza) for children 5 years and older to treat and prevent influenza.
July 08, 2022
The report showed the protective benefits varied somewhat by cardiovascular disease subtype.
June 28, 2022
With the impending start to the 2022-2023 influenza season just a few months away, here is some information on what is being studied for vaccines as well as recommendations and new testing.
June 23, 2022
Podcast
Listen to our interview with Sanofi vaccine expert Dr. Christopher Rizzo about what this preferential recommendation means, and why high-dose flu vaccines are needed for older adults.
May 18, 2022
Data on hospitalizations of children during the pandemic highlighted the seriousness of MIS-C, particularly in children of color.
May 15, 2022
The company is utilizing this platform to address new COVID-19 variants, combination vaccines, and potentially prevent HIV.
April 29, 2022
A Colorado person tested positive for avian influenza. The patient worked closely with poultry, their only symptom was fatigue, and they have since recovered after a few days.
FDA Approval of First Fecal Microbiota Product Ensures Safety in Standardization
Clinician Perspective on the Latest SSTI Antibiotics
Shedding Light on Improvements in COVID-19 Inpatient Outcomes Over Time
Did Overuse of Antibiotics Drive Secondary Infection in COVID-19 Patients?
